Exploring Beta-Caryophyllene’s Therapeutic Potential in Eye-Related Diseases

Ben and Mel have had a few people ask them about Beta Caryophyllene (BCP) and eye health.  This is something that I had not thought much about.  Mel sent me a very interesting research paper that she found, and I was amazed at the potential therapeutic benefits that BCP may have with eye related diseases.  So let’s take as look (no pun intended!).

The human eye is a fascinating organ that provides us with visual experience and allows us to navigate the world around us. Unfortunately, eye-related diseases and disorders can significantly impact our vision and quality of life. However, there is growing interest in natural compounds that may offer therapeutic benefits for these conditions. One such compound is our beloved BCP.

As we know from previous blogs, BCP belongs to the class of chemicals called terpenes. BCP  is found abundantly in nature and has gained attention due to its interactions with the body’s endocannabinoid system (ECS)  As we discovered last week, unlike other cannabinoids, our BCP which is extracted from either black pepper or cloves directly binds to the cannabinoid CB2 receptors. This unique interaction contributes to its potential therapeutic effects in various health conditions, including those affecting the eyes.

Therapeutic Potential in Eye-Related Diseases:

1. Glaucoma: Glaucoma is a group of eye conditions characterised by increased intraocular pressure, leading to optic nerve damage and vision loss. BCP has shown promise in reducing intraocular pressure through its interaction with the CB2 receptors. By modulating the ECS, BCP may help alleviate the pressure on the optic nerve, potentially slowing down the progression of glaucoma.
2. Dry Eye Syndrome: When our eyes don’t produce enough tears or our tears evaporate too quickly, this is called Dry Eye Syndrome. Dry Eye Syndrome can be very painful and cause redness and impaired vision. Because of its anti-inflammatory effects, BCP could potentially help reduce eye surface irritation, enhancing tear production, and alleviating symptoms associated with this illness.
3. Age-Related Macular Degeneration (AMD): AMD is the degeneration of the macular.  The macular is the central part of the retina that is responsible for sharp, central vision. BCP’s antioxidant and anti-inflammatory properties make it a promising candidate for AMD treatment. These properties help protect retinal cells from oxidative stress and inflammation, potentially slowing down the progression of the disease.
4. Retinal Ischemia: Retinal ischemia occurs when there is insufficient blood flow to the retina, leading to retinal cell death and vision impairment. Studies have suggested that BCP’s neuroprotective properties may help mitigate retinal ischemia by reducing oxidative stress, inflammation, and apoptosis (cell death) in retinal cells. By enhancing cell survival, beta-caryophyllene could potentially preserve vision in individuals affected by retinal ischemia.

BCP’s interaction with the CB2 receptors in our endocannabinoid system (ECS) offers exciting possibilities for the treatment and management of conditions such as glaucoma, dry eye syndrome, age-related macular degeneration, and retinal ischemia. As we find constantly, further research is necessary to fully understand its mechanisms of action and to determine optimal dosages and delivery methods.  But, hey, what great news that by using your Canna Oils BCP daily, you just might be protecting yourself against eye disease in the future.

Until next week, keep posting your amazing reviews and remember that we are only an email or phone call away from answering any of the BCP questions.

Sources: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220155/?fbclid=IwAR3KWGLo5Rwvnc2es0UJ_NnmHqNmYPbjbXCFKHduYF4QE1BzJ4RkZueOygA

Disclaimer:  The information in this post is for reference purposes only and not intended to constitute or replace professional medical advice or personal research. Please consult a qualified medical professional before making any changes to your diet, medications or lifestyle. Effects are provided as a guide only.  Statements have not been evaluated by the TGA.